CellaVision AB engages in the provision of digital microscopy solutions for hematology laboratories. The company is headquartered in Lund, Skane and currently employs 228 full-time employees. The company went IPO on 2007-05-28. The firm develops and sells digital solutions for medical microscopy, as well as products enabling blood cell analysis and morphology diagnosis. CellaVision AB’s product portfolio consists of analyzers for automated medical microscopy analysis and software applications designed for remote access, competency testing and education. The analyzers include such brands as CellaVision DM96 and CellaVision DM1200, whereas the software applications are divided into CellaVision Body Fluid Application, CellaVision Remote Review Software and CellaVision Competency Software, among others. The firm operates four subsidiaries, based in Sweden, Canada, the United States and Japan. In June 2014, CellaVision AB acquired technology platform from Clear Lake Medical Foundation.
Follow-Up Questions
What is the price performance of CVLLY stock?
The current price of CVLLY is $0, it has decreased 0% in the last trading day.
What are the primary business themes or industries for CellaVision AB?
CellaVision AB belongs to Health Care industry and the sector is Health Care
What is CellaVision AB market cap?
CellaVision AB's current market cap is $0
Is CellaVision AB a buy, sell, or hold?
According to wall street analysts, 5 analysts have made analyst ratings for CellaVision AB, including 2 strong buy, 5 buy, 1 hold, 0 sell, and 2 strong sell
